title: A safety evaluation of the intravitreal use of a beta-2 agonist in rabbit eyes.
authors.affiliation: Department of Ophthalmology, University Hospitals Leuven, Leuven, Belgium.
authors.forename: Joachim
authors.initials: J
authors.lastname: Van Calster
authors.forename: Sofie
authors.initials: S
authors.lastname: Verstraeten
authors.forename: Rita
authors.initials: R
authors.lastname: Van Ginderdeuren
authors.forename: Evelien
authors.initials: E
authors.lastname: Vandewalle
authors.forename: Ingeborg
authors.initials: I
authors.lastname: Stalmans
authors.forename: Peter
authors.initials: P
authors.lastname: Stalmans
mesh_terms: D058666:Adrenergic beta-2 Receptor Agonists / Q000008:administration & dosage*; D000818:Animals; D002976:Clenbuterol / Q000008:administration & dosage*; D004195:Disease Models, Animal; D058449:Intravitreal Injections; D008297:Male; D011817:Rabbits; D012163:Retinal Detachment / Q000188:drug therapy* / Q000473:pathology; D055213:Retinal Pigment Epithelium / Q000187:drug effects / Q000473:pathology*; D041623:Tomography, Optical Coherence; D016896:Treatment Outcome
chemical_list: D058666:Adrenergic beta-2 Receptor Agonists; D002976:Clenbuterol